These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34099889)

  • 21. Polymorphonuclear myeloid-derived suppressor cells play a proinflammatory role via TNF-α
    Li M; Tang Z; Shu R; Wu H; Wang Y; Chen Z; Cheng Z; Yan X; Zhao N; Tang X; Zhang H; Sun L
    Immunology; 2023 Oct; 170(2):286-300. PubMed ID: 37337447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
    Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
    Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response.
    Li H; Wu H; Guo Q; Yu H; Xu Y; Yu J; Wang Z; Yi H
    Front Immunol; 2020; 11():1777. PubMed ID: 32973748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia.
    Wang Y; Liu Y; Shu C; Wan J; Shan Y; Zhi X; Sun L; Yi H; Yang YG; He J
    J Reprod Immunol; 2018 Jun; 127():48-54. PubMed ID: 29763854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon Regulatory Factor 4 Regulates the Development of Polymorphonuclear Myeloid-Derived Suppressor Cells Through the Transcription of c-Myc in Cancer.
    Yang Q; Xie H; Li X; Feng Y; Xie S; Qu J; Xie A; Zhu Y; Zhou L; Yang J; Hu X; Wei H; Qiu H; Qin W; Huang J
    Front Immunol; 2021; 12():627072. PubMed ID: 33708218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis.
    Satake E; Koga K; Takamura M; Izumi G; Elsherbini M; Taguchi A; Makabe T; Takeuchi A; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Osuga Y
    J Reprod Immunol; 2021 Nov; 148():103371. PubMed ID: 34517223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.
    Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y
    Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
    Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
    Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDSCs in pregnancy: Critical players for a balanced immune system at the feto-maternal interface.
    Ahmadi M; Mohammadi M; Ali-Hassanzadeh M; Zare M; Gharesi-Fard B
    Cell Immunol; 2019 Dec; 346():103990. PubMed ID: 31703912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells.
    Goulart MR; Hlavaty SI; Chang YM; Polton G; Stell A; Perry J; Wu Y; Sharma E; Broxholme J; Lee AC; Szladovits B; Turmaine M; Gribben J; Xia D; Garden OA
    Sci Rep; 2019 Mar; 9(1):3574. PubMed ID: 30837603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA
    Tian X; Zheng Y; Yin K; Ma J; Tian J; Zhang Y; Mao L; Xu H; Wang S
    Cancer Immunol Res; 2020 Apr; 8(4):565-577. PubMed ID: 32102837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants.
    Liu W; Li S; Li Y; Shen W; Chen H; Li X; Cai L; Wu F; Liu Y; Meng Q; Jiang X
    Oxid Med Cell Longev; 2022; 2022():9010354. PubMed ID: 36193058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer Cachexia.
    Dzierlega K; Chakraborty M; Lee M; Soliman AM; Parker D; Khan S; Chan YT; Akbari M; Yokota T; Winer S; Baker K; Tsai S; Winer DA; Clemente-Casares X
    J Immunol; 2023 Aug; 211(3):497-507. PubMed ID: 37294291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
    Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment With Endothelin-A Receptor Antagonist BQ123 Attenuates Acute Inflammation in Mice Through T-Cell-Dependent Polymorphonuclear Myeloid-Derived Suppressor Cell Activation.
    Chen Z; Zhang X; Lv S; Xing Z; Shi M; Li X; Chen M; Zuo S; Tao Y; Xiao G; Liu J; He Y
    Front Immunol; 2021; 12():641874. PubMed ID: 33828553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.